Other cells in the TME can also release factors implicated in immunosuppression, such as VEGF release by tumor vascular cells [137,138]; or myeloid-derived suppressor cells (MDSC) recruited into the TME, which may release T cell inhibitors such as arginase and nitrous oxide synthase [139]. The gene discussed is VEGFA; the disease is neoplasm.